Pew Funds Six Research Teams to Pursue Scientific Discoveries

PHILADELPHIA, Sept. 17, 2019 /PRNewswire/ — The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2019 class of Innovation Fund investigators.

These investigators—alumni of Pew’s biomedical programs in the United States and Latin America—partner on interdisciplinary research to tackle some of the most complex questions in human biology and disease. Spanning the spectrum from virology to epigenetics and from microbiology to developmental biology, research teams combine multiple disciplines to advance scientific discovery and improve human health.

“By leveraging Pew’s biomedical network of over 1,000 scientists, researchers with shared goals can combine expertise to help answer science’s most challenging questions,” said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. “We are proud to support this year’s class of investigators in their joint efforts to unlock groundbreaking discoveries.”

For nearly 35 years, Pew has encouraged collaboration among its diverse community of biomedical scientists, culminating in the launch of the Innovation Fund in 2017. The fund’s award criteria were developed to promote synergy among program alumni, motivating researchers to collaborate on new proposals. All alumni holding assistant professor positions or higher are eligible to apply for the award, which is supported by the Kathryn W. Davis Peace by Pieces Fund.

This year’s Innovation Fund teams and research projects are:

Ariel A. Bazzini, Ph.D., 2010 Pew Latin American fellow; Stowers Institute for Medical Research

Diego E. Alvarez, Ph.D., 2009 Pew Latin American fellow; National University of San Martín

Bazzini and Alvarez will investigate how the dengue virus manipulates host cells in order to replicate during infection.

Fernando Camargo, Ph.D., 2010 Pew biomedical scholar; Boston Children’s Hospital, Harvard University

Alexander A. Gimelbrant, Ph.D., 2010 Pew biomedical scholar; Dana-Farber Cancer Institute

Camargo and Gimelbrant will explore how genetically identical organisms can look and function differently.

Jeannie T. Lee, M.D., Ph.D., 1999 Pew biomedical scholar; Massachusetts General Hospital, Harvard University

Raymond J. Kelleher III, M.D., Ph.D., 2006 Pew biomedical scholar; Massachusetts General Hospital, Harvard University

Drs. Lee and Kelleher will study how the inheritance of the X chromosome from either the mother or father influences behavior and cognition, using Turner syndrome as a model.

Ruth Lehmann, Ph.D., Pew scholar adviser; New York University

Agnel Sfeir, Ph.D., 2014 Pew-Stewart scholar; New York University

Lehmann and Sfeir will develop tools to examine how mitochondrial DNA is inherited by offspring.  

Julie K. Pfeiffer, Ph.D., 2007 Pew biomedical scholar; University of Texas Southwestern Medical Center

Nicole King, Ph.D., 2004 Pew biomedical scholar; University of California, Berkeley

Pfeiffer and King will explore the innate immune response in aquatic, unicellular organisms called choanoflagellates.  

Wesley Sundquist, Ph.D., Pew scholar adviser; University of Utah

Nels C. Elde, Ph.D., 2012 Pew biomedical scholar; University of Utah

Sundquist and Elde will evaluate a protein found in certain kinds of monkeys that is known to provide resistance against viral infections and determine whether it is able to do the same in other animals.

The Pew Charitable Trusts is driven by the power of knowledge to solve today’s most challenging problems. Learn more at pewtrusts.org.

CONTACT: Erin Davis, 202-540-6677, edavis@pewtrusts.org

View original content:http://www.prnewswire.com/news-releases/pew-funds-six-research-teams-to-pursue-scientific-discoveries-300919827.html

SOURCE The Pew Charitable Trusts

Staff

Recent Posts

Med Holdings Group, Inc. (FKA Yuka Group, Inc.) Announces Acquisition Of Medsmart Wellness Centers, Inc.

DENVER, CO / ACCESSWIRE / March 22, 2024 / (OTC Pink:YUKA) Med Holdings Group, Inc.…

38 mins ago

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a…

4 hours ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases…

4 hours ago

Smartsheet Names Katie Rooney to Board of Directors

Experienced global CFO adds depth in financial strategy and operating excellence to Smartsheet boardBELLEVUE, Wash.--(BUSINESS…

4 hours ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic…

4 hours ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…

5 hours ago